|
|
||||||||


,§
*
Department of Surgery, University of Wisconsin, Madison, WI 53792;
Argonex Pharmaceuticals, Charlottesville, VA 22903;
Department of Immunohaematology and Bloodbank, Leiden University Hospital, Leiden, The Netherlands;
§
SVM-Foundation for the Advancement of Public Health and Environmental Protection, Bilthoven, The Netherlands; and
¶
Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595
Soluble MHC Ags and anti-Id (anti-anti-MHC) Abs have
both been shown to inhibit MHC alloantigen-specific B cell responses in
vivo. We hypothesized that some anti-idiotypic Abs function as
divalent molecular mimics of soluble HLA alloantigen. To test this
idea, we studied two well-defined anti-idiotypic mAbs, T10-505 and
T10-938, elicited in syngeneic BALB/c mice by immunization with
CRll-351, an HLA-A2,24,28-specific mAb. Each anti-Id induced
"Ab-3" Abs in rabbits that cross-reacted with HLA-A2 but not with
HLA-B Ags. Furthermore, each anti-Id could bind to and block Ag
recognition by Ha5C2.A2, a human homologue of mAb CRll-351. Both
anti-Id mAb displayed weak reactivity with the human mAb SN66E3,
which recognized an overlapping but distinct determinant of HLA-A2 Ags;
neither reacted with human mAb MBW1, which recognized a nonoverlapping
HLA-A2 determinant. Amino acid sequence comparison of mAb CRll-351
heavy and light chain variable region complementarity-determining
regions (CDRs) with those of mAb Ha5C2.A2 and SN66E3 revealed short
regions of homology with both human mAb; a large insert in the light
chain CDR1 of mAb SN66E3 distinguished it from both CRll-351 and
Ha5C2.A2. The amino acid sequences of mAb T10-505 and T10-938, which
differed markedly from each other, revealed no homology to the
2
domain sequence of HLA-A*0201 that contains the CRll-351 mAb-defined
epitope. We conclude that structurally different anti-Id Abs can
mimic a polymorphic conformational epitope of an HLA Ag. In the case of
T10-505 and T10-938 mimicry was not based on exact replication of the
epitope by the hypervariable loops of the anti-Id
mAb.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |